Abstract:Background Cardiac Resynchronization Therapy (CRT) stands as an established intervention for selected patients with heart failure (HF) presenting with a wide QRS complex. The optimal timing for CRT implantation remains uncertain. Current evidence suggests superior outcomes post-CRT in patients who have not been previously hospitalised for HF and those receiving the implant during their initial hospitalisation for HF.1 Purpose The primary objective of this study is to investigate the long-term clinical outcomes following CRT implantation relative to the duration of HF previous to the implant. It was analysed in a cohort of consecutive patients from a HF Unit who met the criteria for CRT as recommended by the ESC guidelines (QRS duration ≥150ms, left bundle branch block morphology, and left ventricular ejection fraction (LVEF) ≤35% despite optimal medical therapy). Methods We evaluated all patients who received CRT from January 2011 through September 2022. Follow-up ended in September 2023. Patients with CRT indicated for ventricular pacing due to high-degree atrioventricular block were excluded. Patients were categorized into two groups based on the duration of HF progression prior to CRT implantation: more than 3 years and 3 years or less. The primary outcome was all-cause mortality (ACM). Secondary outcomes included a composite of ACM and HF hospitalisation and the proportion of patients who demonstrated a significant improvement in LVEF (defined as an increase of ≥10% from baseline and a subsequent measurement of LVEF ≥40%). Results The cohort consisted of 127 patients, mean age 65.8±10.7 years, 23.6% were women, mean LVEF was 28.4±8.6% and 36.2% had ischaemic aetiology (Table 1). 62 patients either died or were hospitalized for HF. Mean follow-up was 4.9±2.7 years. After adjusting for age, sex and baseline LVEF, patients with HF for more than three years before CRT implantation had a worse prognosis: HRs of 2.31 for ACM (p=0.016) and 2.13 for the combined endpoint of ACM+HFH (p=0.010) (Figure 1). The proportion of patients with improved LVEF after CRT was significantly higher in the group with shorter HF duration (68.25%) compared to the group with longer HF duration (25%), p <0.001. Conclusions Our findings reveal that patients with a shorter history of HF (less than three years) prior to CRT implantation exhibit significantly better clinical outcomes. These results highlight the role of early intervention with CRT in patients with HF, suggesting that shorter HF duration prior to CRT may lead to more favourable long-term outcomes.

Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

Predictors for Cardiac Resynchronization Therapy Response

Ventricular-Arterial Coupling in Patients with Heart Failure Treated with Cardiac Resynchronization Therapy: May We Predict the Long-Term Clinical Response?

Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance

Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy

Value of QRS duration in predicting clinical response to cardiac resynchronization therapy in patients with end-stage heart failure

An S Wave in ECG Lead V6 Predicts Poor Response to Cardiac Resynchronization Therapy and Long-Term Outcome.

Reduced Mitral Regurgitation in Heart Failure Patients Submitted to Cardiac Resynchronization Therapy: a Short-Term Prospective Study.

Right ventricular systolic function and cardiac resynchronization therapy

CRT Response Score Predicts the Effects of Cardiac Resynchronisation Therapy

Regional Left Ventricular Fiber Stress Analysis for Cardiac Resynchronization Therapy Response

Value of QRS duration in predicting response to cardiac resynchronization therapy in patients with end-stage heart failure

The Mosaic of Cardiac Resynchronization Therapy Responders—A Comprehensive Exploration of Diverse Criteria and Predictors

Predictors of Response to Cardiac Resynchronization Therapy in Pediatric and Congenital Heart Disease Patients

[Factors Associated with Efficacy of Cardiac Resynchronization Therapy for Patients with Congestive Heart Failure].

Beating the clock: the impact of heart failure duration on CRT efficacy

Multivariate analyse of effects on cardiac resynchronization therapy in patients with heart failure

Understanding Nonresponders of Cardiac Resynchronization Therapy—Current and Future Perspectives

Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease

Predictive Value of Clinical and Echocardiographic Parameters on Cardiac Resynchronization Therapy